Business Wire

Marrakech Investor Day: International Investors are Choosing Marrakech, One of the World’s Dream Destinations

7.4.2022 12:28:00 EEST | Business Wire | Press release

Share

In collaboration with the International Finance Corporation (IFC) and the Swiss State Secretariat for Economic Affairs (SECO), the Marrakech-Safi Regional Center for Investment hosted the inaugural edition of the Marrakech Investor Day, a meaningful event designed to allow hundreds of investors to explore the fantastic advantages and new investment opportunities across Marrakech.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220407005464/en/

Global supply chain disruptions, recent geopolitical changes, and the “Green Production” requirement, coupled with the multiple free trade agreements that provide direct access to more than 1.3 billion consumers, have aptly positioned Marrakech as the sustainable alternative for investors around the world.

Marrakech is a captivating imperial city boasting a sub-tropical mild climate and beautiful landscapes that make it an unmissable tourist destination. Moreover, Morocco provides attractive advantages for investors from all over the world. These advantages include political stability, a geo-strategic location and direct access to Europe and Africa’s markets, an attractive business-friendly environment, a robust, modern infrastructure, and prestigious talents taught in two of Africa’s best universities, all combined with a unique lifestyle and improved quality of life.

Marrakech, a city at the forefront of sustainability

Driven by the unrelenting will of the King of Morocco, with a target to generate 52% of energy from renewable sources by 2030, Marrakech offers investors the opportunity to put a little “green” in their portfolios and decarbonize the world’s industries.

The event was also an opportunity to explore the cultural richness and diversity of Marrakech, which actively encourages and facilitates foreign investments in multiple sectors, such as the agribusiness, tourism, creative industries, renewable energy, logistics, offshoring, and ICT.

These investment opportunities were made possible thanks to multiple reforms and facilitation mechanisms, which offer several incentives to stimulate investment (up to 30% of the total investment amount), improve the business climate and the competitiveness of the private sector.

More than 50 non-double taxation agreements, the absence of restrictions in the percentage of share capital and the free repatriation of funds are also influential factors that enable the region to offer a particularly modern and attractive legal and fiscal environment.

As part of the Marrakech Investor Day’s events, international investors were given a first-hand demonstration of these advantages that promote ease of doing investments in Marrakech and enhance transparency, such as the dematerialization of customs procedures and the personalized support of the Marrakech-Safi Regional Center for Investment.

The event also featured a panel discussion on the data-related investment opportunities, followed by the Marrakech Investor Awards ceremony, designed to celebrate the regions’ key investors.

To relive the event, and learn more about investment opportunities in Marrakech, visit www.marrakechinvest.ma

About:

The Regional Investment Center of Marrakech-Safi is a public institution with a mission is to facilitate, support and promote investments in the Marrakech-Safi region.

*Source: AETOSWire

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Hanaa Zouzaf
h.zouzaf@crimarrakech.ma

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz ® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 16:29:00 EET | Press release

Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “Today’s positive CHMP opinion is an important step towards addressing the urgent need for new treatment options for patients in Europe with advanced SCAC, a disease which has seen limited innovation for decades,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved, Zynyz in combination with platinum-based chemotherapy has the potential to become a new standard-of-care for patients living with this rare and difficult-to-treat cancer.” The positive CHMP opinion was based on data from the Phase 3 POD1UM-303/Inter

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 14:32:00 EET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 10:00:00 EET | Press release

With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerful, secure, reliable, and intelligent digital signage,” said Steve Durkee, chief executive office

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 09:30:00 EET | Press release

Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, supported by one of the largest bodies of published clinical data backed by decades of clinica

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 09:00:00 EET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye